Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Form 8.5 (EPT/NON-RI)

6th May 2014 07:01

RNS Number : 2575G
Goldman Sachs & Co.
05 May 2014
 



 

FORM 8.5 (EPT/NON-RI)

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITHOUT RECOGNISED INTERMEDIARY ("RI") STATUS (OR WHERE RI STATUS IS NOT APPLICABLE)

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

(GS) GOLDMAN, SACHS & CO.

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

ASTRAZENECA PLC

(c) Name of the party to the offer with which exempt principal trader is connected:

ASTRAZENECA PLC

(d) Date position held/dealing undertaken:

02 May 2014

(e) Has the EPT previously disclosed, or is it today disclosing, under the Code in respect of any other party to this offer?

NO

 

2. POSITIONS OF THE EXEMPT PRINCIPAL TRADER

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

ADRs

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

858

0.00

0

0.00

(2) Derivatives (other than options):

0

0.00

0

0.00

(3) Options and agreements to purchase/sell:

0

0.00

0

0.00

 

TOTAL:

858

0.00

0

0.00

 

 

 

All interests and all short positions should be disclosed.

 

Details of any open derivative or option positions, or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other executive options)

 

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

3. DEALINGS (IF ANY) BY THE EXEMPT PRINCIPAL TRADER

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

ADR

Purchase

200

80.9000 USD

ADR

Purchase

400

80.9100 USD

ADR

Purchase

100

80.9100 USD

ADR

Purchase

100

80.9100 USD

ADR

Purchase

100

80.9100 USD

ADR

Purchase

100

80.9100 USD

ADR

Purchase

100

80.9100 USD

ADR

Purchase

400

80.9100 USD

ADR

Purchase

400

80.9200 USD

ADR

Purchase

100

80.9200 USD

ADR

Purchase

200

80.9200 USD

ADR

Purchase

100

80.9200 USD

ADR

Purchase

100

80.9200 USD

ADR

Purchase

400

80.9200 USD

ADR

Purchase

100

80.9200 USD

ADR

Purchase

100

80.9200 USD

ADR

Purchase

200

80.9300 USD

ADR

Purchase

100

80.9300 USD

ADR

Purchase

300

80.9300 USD

ADR

Purchase

400

80.9400 USD

ADR

Purchase

100

80.9400 USD

ADR

Purchase

200

80.9400 USD

ADR

Purchase

700

80.9400 USD

ADR

Purchase

95

80.9500 USD

ADR

Purchase

300

80.9500 USD

ADR

Purchase

300

80.9500 USD

ADR

Purchase

100

80.9500 USD

ADR

Purchase

100

80.9500 USD

ADR

Purchase

1

80.9600 USD

ADR

Purchase

100

80.9600 USD

ADR

Purchase

100

80.9600 USD

ADR

Purchase

100

80.9600 USD

ADR

Purchase

100

80.9600 USD

ADR

Purchase

100

80.9600 USD

ADR

Purchase

100

80.9700 USD

ADR

Purchase

100

80.9700 USD

ADR

Purchase

100

80.9700 USD

ADR

Purchase

200

80.9800 USD

ADR

Purchase

100

80.9800 USD

ADR

Purchase

100

80.9800 USD

ADR

Purchase

100

80.9800 USD

ADR

Purchase

100

81.0000 USD

ADR

Purchase

100

81.0000 USD

ADR

Purchase

100

81.0000 USD

ADR

Purchase

100

81.0000 USD

ADR

Purchase

100

81.0000 USD

ADR

Purchase

100

81.0000 USD

ADR

Purchase

100

81.0000 USD

ADR

Purchase

100

81.0000 USD

ADR

Purchase

200

81.0200 USD

ADR

Purchase

100

81.0200 USD

ADR

Purchase

200

81.0200 USD

ADR

Purchase

200

81.0200 USD

ADR

Purchase

100

81.0200 USD

ADR

Purchase

200

81.0300 USD

ADR

Purchase

100

81.0300 USD

ADR

Purchase

600

81.0400 USD

ADR

Purchase

200

81.0400 USD

ADR

Purchase

200

81.0400 USD

ADR

Purchase

300

81.0400 USD

ADR

Purchase

100

81.0400 USD

ADR

Purchase

100

81.0500 USD

ADR

Purchase

200

81.0600 USD

ADR

Purchase

100

81.0600 USD

ADR

Purchase

200

81.0700 USD

ADR

Purchase

200

81.0700 USD

ADR

Purchase

100

81.0700 USD

ADR

Purchase

300

81.0800 USD

ADR

Purchase

300

81.0800 USD

ADR

Purchase

400

81.0800 USD

ADR

Purchase

54

81.1000 USD

ADR

Purchase

300

81.1000 USD

ADR

Purchase

200

81.1000 USD

ADR

Purchase

100

81.1000 USD

ADR

Purchase

46

81.1000 USD

ADR

Purchase

700

81.1000 USD

ADR

Purchase

600

81.1000 USD

ADR

Purchase

100

81.1100 USD

ADR

Purchase

100

81.1100 USD

ADR

Purchase

100

81.1100 USD

ADR

Purchase

400

81.1200 USD

ADR

Purchase

300

81.1300 USD

ADR

Purchase

200

81.1300 USD

ADR

Purchase

400

81.1300 USD

ADR

Purchase

100

81.1300 USD

ADR

Purchase

100

81.1500 USD

ADR

Purchase

200

81.1500 USD

ADR

Purchase

100

81.1500 USD

ADR

Purchase

700

81.1500 USD

ADR

Purchase

100

81.1900 USD

ADR

Purchase

300

81.1900 USD

ADR

Purchase

500

81.2000 USD

ADR

Purchase

100

81.2100 USD

ADR

Purchase

300

81.2200 USD

ADR

Purchase

200

81.2300 USD

ADR

Purchase

500

81.2400 USD

ADR

Purchase

600

81.2400 USD

ADR

Purchase

100

81.2500 USD

ADR

Purchase

300

81.2600 USD

ADR

Purchase

300

81.2700 USD

ADR

Purchase

300

81.4200 USD

ADR

Purchase

200

81.4400 USD

ADR

Purchase

60

81.4500 USD

ADR

Sale

100

80.8300 USD

ADR

Sale

200

80.8500 USD

ADR

Sale

100

80.8500 USD

ADR

Sale

100

80.8500 USD

ADR

Sale

100

80.8500 USD

ADR

Sale

200

80.8600 USD

ADR

Sale

100

80.8700 USD

ADR

Sale

100

80.8700 USD

ADR

Sale

100

80.8700 USD

ADR

Sale

100

80.8800 USD

ADR

Sale

181

80.8800 USD

ADR

Sale

400

80.9000 USD

ADR

Sale

100

80.9100 USD

ADR

Sale

400

80.9100 USD

ADR

Sale

100

80.9100 USD

ADR

Sale

100

80.9200 USD

ADR

Sale

100

80.9300 USD

ADR

Sale

100

80.9300 USD

ADR

Sale

100

80.9300 USD

ADR

Sale

100

80.9300 USD

ADR

Sale

100

80.9300 USD

ADR

Sale

100

80.9400 USD

ADR

Sale

100

80.9400 USD

ADR

Sale

100

80.9400 USD

ADR

Sale

200

80.9400 USD

ADR

Sale

100

80.9600 USD

ADR

Sale

386

80.9600 USD

ADR

Sale

200

80.9600 USD

ADR

Sale

100

80.9600 USD

ADR

Sale

100

80.9700 USD

ADR

Sale

200

80.9700 USD

ADR

Sale

79

80.9800 USD

ADR

Sale

100

80.9800 USD

ADR

Sale

100

80.9800 USD

ADR

Sale

600

80.9800 USD

ADR

Sale

200

80.9800 USD

ADR

Sale

28

80.9900 USD

ADR

Sale

17

80.9900 USD

ADR

Sale

100

80.9900 USD

ADR

Sale

200

80.9900 USD

ADR

Sale

58

80.9900 USD

ADR

Sale

100

80.9900 USD

ADR

Sale

200

81.0000 USD

ADR

Sale

100

81.0000 USD

ADR

Sale

100

81.0000 USD

ADR

Sale

200

81.0000 USD

ADR

Sale

100

81.0000 USD

ADR

Sale

200

81.0000 USD

ADR

Sale

500

81.0000 USD

ADR

Sale

100

81.0100 USD

ADR

Sale

100

81.0100 USD

ADR

Sale

100

81.0100 USD

ADR

Sale

100

81.0100 USD

ADR

Sale

100

81.0100 USD

ADR

Sale

100

81.0100 USD

ADR

Sale

300

81.0200 USD

ADR

Sale

107

81.0200 USD

ADR

Sale

100

81.0200 USD

ADR

Sale

100

81.0300 USD

ADR

Sale

200

81.0300 USD

ADR

Sale

100

81.0300 USD

ADR

Sale

100

81.0300 USD

ADR

Sale

100

81.0300 USD

ADR

Sale

100

81.0400 USD

ADR

Sale

100

81.0400 USD

ADR

Sale

200

81.0400 USD

ADR

Sale

200

81.0400 USD

ADR

Sale

300

81.0400 USD

ADR

Sale

200

81.0400 USD

ADR

Sale

600

81.0500 USD

ADR

Sale

100

81.0500 USD

ADR

Sale

100

81.0500 USD

ADR

Sale

200

81.0600 USD

ADR

Sale

100

81.0600 USD

ADR

Sale

100

81.0600 USD

ADR

Sale

200

81.0600 USD

ADR

Sale

100

81.0600 USD

ADR

Sale

200

81.0600 USD

ADR

Sale

200

81.0700 USD

ADR

Sale

100

81.0700 USD

ADR

Sale

100

81.0700 USD

ADR

Sale

100

81.0700 USD

ADR

Sale

200

81.0700 USD

ADR

Sale

100

81.0700 USD

ADR

Sale

100

81.0800 USD

ADR

Sale

100

81.0800 USD

ADR

Sale

200

81.0800 USD

ADR

Sale

300

81.0900 USD

ADR

Sale

200

81.0900 USD

ADR

Sale

100

81.0900 USD

ADR

Sale

100

81.1000 USD

ADR

Sale

100

81.1000 USD

ADR

Sale

100

81.1000 USD

ADR

Sale

100

81.1000 USD

ADR

Sale

100

81.1000 USD

ADR

Sale

100

81.1100 USD

ADR

Sale

400

81.1200 USD

ADR

Sale

100

81.1200 USD

ADR

Sale

200

81.1200 USD

ADR

Sale

200

81.1200 USD

ADR

Sale

100

81.1200 USD

ADR

Sale

100

81.1200 USD

ADR

Sale

100

81.1300 USD

ADR

Sale

200

81.1300 USD

ADR

Sale

300

81.1500 USD

ADR

Sale

100

81.1500 USD

ADR

Sale

100

81.1500 USD

ADR

Sale

300

81.1600 USD

ADR

Sale

100

81.1700 USD

ADR

Sale

100

81.1700 USD

ADR

Sale

100

81.1700 USD

ADR

Sale

200

81.1800 USD

ADR

Sale

400

81.2100 USD

ADR

Sale

300

81.2100 USD

ADR

Sale

100

81.2100 USD

ADR

Sale

200

81.2100 USD

ADR

Sale

300

81.2100 USD

ADR

Sale

9

81.2100 USD

ADR

Sale

200

81.2100 USD

ADR

Sale

100

81.2100 USD

ADR

Sale

100

81.2200 USD

ADR

Sale

100

81.2200 USD

ADR

Sale

300

81.2200 USD

ADR

Sale

92

81.2200 USD

ADR

Sale

400

81.2200 USD

ADR

Sale

100

81.2400 USD

ADR

Sale

100

81.2400 USD

ADR

Sale

200

81.2500 USD

ADR

Sale

200

81.2700 USD

ADR

Sale

400

81.2900 USD

ADR

Sale

100

81.3000 USD

ADR

Sale

100

81.4200 USD

 

 

Class of relevant security

Purchases/sales

Total number of securities

ADR

Purchases

21,056

ADR

Sales

20,957

 

(b) Derivatives transactions (other than options)

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

(c) Options transactions in respect of existing securities

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

 

(ii) Exercising

 

Class of relevant security

Product description

e.g. call option

Number of securities

Exercise price per unit

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

The currency of all prices and other monetary amounts should be stated.

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

If there are no such agreements, arrangements or understandings, state "none"

 

NONE

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

NONE

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

 

 

Date of disclosure:

05 May 2014

Contact name:

Helen-Marie Moloney and Christopher Owers

Telephone number:

+44(20) 7774 8019 / +44(20) 7552 1461

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at [email protected]. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FEOAAMMTMBIMBLI

Related Shares:

Astrazeneca
FTSE 100 Latest
Value8,275.66
Change0.00